A citation-based method for searching scientific literature

Qingchun Zeng, Qing Zhou, Weitao Liu, Yutong Wang, Xingbo Xu, Dingli Xu. Front Cardiovasc Med 2021
Times Cited: 3







List of co-cited articles
5 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.
Milton Packer, Stefan D Anker, Javed Butler, Gerasimos Filippatos, Stuart J Pocock, Peter Carson, James Januzzi, Subodh Verma, Hiroyuki Tsutsui, Martina Brueckmann,[...]. N Engl J Med 2020
736
66

Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors).
Mikhail Kosiborod, Matthew A Cavender, Alex Z Fu, John P Wilding, Kamlesh Khunti, Reinhard W Holl, Anna Norhammar, Kåre I Birkeland, Marit Eika Jørgensen, Marcus Thuresson,[...]. Circulation 2017
464
66

2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee.
Thomas M Maddox, James L Januzzi, Larry A Allen, Khadijah Breathett, Javed Butler, Leslie L Davis, Gregg C Fonarow, Nasrien E Ibrahim, JoAnn Lindenfeld, Frederick A Masoudi,[...]. J Am Coll Cardiol 2021
107
66

Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial.
Michael E Nassif, Sheryl L Windsor, Fengming Tang, Yevgeniy Khariton, Mansoor Husain, Silvio E Inzucchi, Darren K McGuire, Bertram Pitt, Benjamin M Scirica, Bethany Austin,[...]. Circulation 2019
137
66

Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure.
Deepak L Bhatt, Michael Szarek, P Gabriel Steg, Christopher P Cannon, Lawrence A Leiter, Darren K McGuire, Julia B Lewis, Matthew C Riddle, Adriaan A Voors, Marco Metra,[...]. N Engl J Med 2021
263
66


Treatment of chronic heart failure in the 21st century: A new era of biomedical engineering has come.
Chun-Song Hu, Qing-Hua Wu, Da-Yi Hu, Tengiz Tkebuchava. Chronic Dis Transl Med 2018
5
33

Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials.
Yuliya Lytvyn, Petter Bjornstad, Jacob A Udell, Julie A Lovshin, David Z I Cherney. Circulation 2017
208
33

Involvement of NADPH oxidases in cardiac remodelling and heart failure.
Alexander Sirker, Min Zhang, Colin Murdoch, Ajay M Shah. Am J Nephrol 2007
63
33

Shift to Fatty Substrate Utilization in Response to Sodium-Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients With Type 2 Diabetes.
Ele Ferrannini, Simona Baldi, Silvia Frascerra, Brenno Astiarraga, Tim Heise, Roberto Bizzotto, Andrea Mari, Thomas R Pieber, Elza Muscelli. Diabetes 2016
283
33

Angiotensin-neprilysin inhibition versus enalapril in heart failure.
John J V McMurray, Milton Packer, Akshay S Desai, Jianjian Gong, Martin P Lefkowitz, Adel R Rizkala, Jean L Rouleau, Victor C Shi, Scott D Solomon, Karl Swedberg,[...]. N Engl J Med 2014
33

Empagliflozin lessened cardiac injury and reduced visceral adipocyte hypertrophy in prediabetic rats with metabolic syndrome.
Hiroaki Kusaka, Nobutaka Koibuchi, Yu Hasegawa, Hisao Ogawa, Shokei Kim-Mitsuyama. Cardiovasc Diabetol 2016
77
33

Efficacy and safety of SGLT2 inhibitors in heart failure: systematic review and meta-analysis.
Javed Butler, Muhammad Shariq Usman, Muhammad Shahzeb Khan, Stephen J Greene, Tim Friede, Muthiah Vaduganathan, Gerasimos Filippatos, Andrew J Stewart Coats, Stefan D Anker. ESC Heart Fail 2020
19
33

Time to Clinical Benefit of Dapagliflozin and Significance of Prior Heart Failure Hospitalization in Patients With Heart Failure With Reduced Ejection Fraction.
David D Berg, Pardeep S Jhund, Kieran F Docherty, Sabina A Murphy, Subodh Verma, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Anna Maria Langkilde, Felipe A Martinez,[...]. JAMA Cardiol 2021
21
33

Ketone bodies for the starving heart.
P Christian Schulze, Jasmine M F Wu. Nat Metab 2020
6
33

Inhibiting mitochondrial Na+/Ca2+ exchange prevents sudden death in a Guinea pig model of heart failure.
Ting Liu, Eiki Takimoto, Veronica L Dimaano, Deeptankar DeMazumder, Sarah Kettlewell, Godfrey Smith, Agnieszka Sidor, Theodore P Abraham, Brian O'Rourke. Circ Res 2014
104
33

Heart disease and stroke statistics--2015 update: a report from the American Heart Association.
Dariush Mozaffarian, Emelia J Benjamin, Alan S Go, Donna K Arnett, Michael J Blaha, Mary Cushman, Sarah de Ferranti, Jean-Pierre Després, Heather J Fullerton, Virginia J Howard,[...]. Circulation 2015
33

Heart failure in the last year: progress and perspective.
Daniela Tomasoni, Marianna Adamo, Markus S Anker, Stephan von Haehling, Andrew J S Coats, Marco Metra. ESC Heart Fail 2020
10
33

Effects and safety of SGLT2 inhibitors compared to placebo in patients with heart failure: A systematic review and meta-analysis.
Diego Chambergo-Michilot, Astrid Tauma-Arrué, Silvana Loli-Guevara. Int J Cardiol Heart Vasc 2020
7
33

Effects of Sodium-Glucose Co-transporter 2 Inhibition with Empaglifozin on Renal Structure and Function in Non-diabetic Rats with Left Ventricular Dysfunction After Myocardial Infarction.
Salva R Yurista, Herman H W Silljé, Harry van Goor, Jan-Luuk Hillebrands, Hiddo J L Heerspink, Luiz de Menezes Montenegro, Silke U Oberdorf-Maass, Rudolf A de Boer, B Daan Westenbrink. Cardiovasc Drugs Ther 2020
9
33

Role of nitric oxide and peroxynitrite in the cytokine-induced sustained myocardial dysfunction in dogs in vivo.
J i Oyama, H Shimokawa, H Momii, X Cheng, N Fukuyama, Y Arai, K Egashira, H Nakazawa, A Takeshita. J Clin Invest 1998
87
33

SGLT-2 Inhibitors in Heart Failure: Current Management, Unmet Needs, and Therapeutic Prospects.
Carolyn S P Lam, Chanchal Chandramouli, Vineeta Ahooja, Subodh Verma. J Am Heart Assoc 2019
64
33

3
33


Plasma cytokine parameters and mortality in patients with chronic heart failure.
M Rauchhaus, W Doehner, D P Francis, C Davos, M Kemp, C Liebenthal, J Niebauer, J Hooper, H D Volk, A J Coats,[...]. Circulation 2000
601
33

Glucose Metabolism in Cardiac Hypertrophy and Heart Failure.
Diem H Tran, Zhao V Wang. J Am Heart Assoc 2019
46
33

Potential mechanisms responsible for cardioprotective effects of sodium-glucose co-transporter 2 inhibitors.
Sarayut Lahnwong, Siriporn C Chattipakorn, Nipon Chattipakorn. Cardiovasc Diabetol 2018
64
33


Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
Stephen D Wiviott, Itamar Raz, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Michael G Silverman, Thomas A Zelniker, Julia F Kuder, Sabina A Murphy,[...]. N Engl J Med 2019
33

Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction.
Omar F AbouEzzeddine, Paul M McKie, Shannon M Dunlay, Susanna R Stevens, G Michael Felker, Barry A Borlaug, Horng H Chen, Russell P Tracy, Eugene Braunwald, Margaret M Redfield. J Am Heart Assoc 2017
41
33

Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study.
Frederick A Masoudi, Silvio E Inzucchi, Yongfei Wang, Edward P Havranek, JoAnne M Foody, Harlan M Krumholz. Circulation 2005
352
33

Impact of diabetes on the predictive value of heart failure biomarkers.
Nuria Alonso, Josep Lupón, Jaume Barallat, Marta de Antonio, Mar Domingo, Elisabet Zamora, Pedro Moliner, Amparo Galán, Javier Santesmases, Cruz Pastor,[...]. Cardiovasc Diabetol 2016
31
33

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.
Michael R MacDonald, Mark C Petrie, Fumi Varyani, Jan Ostergren, Eric L Michelson, James B Young, Scott D Solomon, Christopher B Granger, Karl Swedberg, Salim Yusuf,[...]. Eur Heart J 2008
368
33

Glycaemic variability in diabetes: clinical and therapeutic implications.
Antonio Ceriello, Louis Monnier, David Owens. Lancet Diabetes Endocrinol 2019
157
33


Dapagliflozin effects on lung fluid volumes in patients with heart failure and reduced ejection fraction: Results from the DEFINE-HF trial.
Michael E Nassif, Sheryl L Windsor, Fengming Tang, Mansoor Husain, Silvio E Inzucchi, Darren K McGuire, Bertram Pitt, Benjamin M Scirica, Bethany Austin, Michael W Fong,[...]. Diabetes Obes Metab 2021
3
33

Association of Long-term Change and Variability in Glycemia With Risk of Incident Heart Failure Among Patients With Type 2 Diabetes: A Secondary Analysis of the ACCORD Trial.
Matthew W Segar, Kershaw V Patel, Muthiah Vaduganathan, Melissa C Caughey, Javed Butler, Gregg C Fonarow, Justin L Grodin, Darren K McGuire, Ambarish Pandey. Diabetes Care 2020
8
33

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.
Marc A Pfeffer, John J V McMurray, Eric J Velazquez, Jean-Lucien Rouleau, Lars Køber, Aldo P Maggioni, Scott D Solomon, Karl Swedberg, Frans Van de Werf, Harvey White,[...]. N Engl J Med 2003
33

Guideline recommendations and the positioning of newer drugs in type 2 diabetes care.
Nikolaus Marx, Melanie J Davies, Peter J Grant, Chantal Mathieu, John R Petrie, Francesco Cosentino, John B Buse. Lancet Diabetes Endocrinol 2021
26
33

2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
John B Buse, Deborah J Wexler, Apostolos Tsapas, Peter Rossing, Geltrude Mingrone, Chantal Mathieu, David A D'Alessio, Melanie J Davies. Diabetes Care 2020
358
33

Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF).
David Preiss, Dirk J van Veldhuisen, Naveed Sattar, Henry Krum, Karl Swedberg, Harry Shi, John Vincent, Stuart J Pocock, Bertram Pitt, Faiez Zannad,[...]. Eur J Heart Fail 2012
37
33

Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study.
Mikhail Kosiborod, Carolyn S P Lam, Shun Kohsaka, Dae Jung Kim, Avraham Karasik, Jonathan Shaw, Navdeep Tangri, Su-Yen Goh, Marcus Thuresson, Hungta Chen,[...]. J Am Coll Cardiol 2018
230
33

Sodium-glucose cotransporter 2 inhibitor versus metformin as first-line therapy in patients with type 2 diabetes mellitus: a multi-institution database study.
Tien-Hsing Chen, Yan-Rong Li, Shao-Wei Chen, Yu-Sheng Lin, Chi-Chin Sun, Dong-Yi Chen, Chun-Tai Mao, Michael Wu, Chih-Hsiang Chang, Pao-Hsien Chu,[...]. Cardiovasc Diabetol 2020
4
33

2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure.
Justin A Ezekowitz, Eileen O'Meara, Michael A McDonald, Howard Abrams, Michael Chan, Anique Ducharme, Nadia Giannetti, Adam Grzeslo, Peter G Hamilton, George A Heckman,[...]. Can J Cardiol 2017
278
33

Galectin-3 in heart failure with preserved ejection fraction.
Rudolf A de Boer, Frank Edelmann, Alain Cohen-Solal, Mamas A Mamas, Alan Maisel, Burkert Pieske. Eur J Heart Fail 2013
69
33

Clinical characteristics and outcomes of patients with and without diabetes in the Surgical Treatment for Ischemic Heart Failure (STICH) trial.
Michael R MacDonald, Lilin She, Torsten Doenst, Philip F Binkley, Jean L Rouleau, Ru-San Tan, Kerry L Lee, Alan B Miller, George Sopko, Dominika Szalewska,[...]. Eur J Heart Fail 2015
17
33

Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na+/H+ exchanger, lowering of cytosolic Na+ and vasodilation.
Laween Uthman, Antonius Baartscheer, Boris Bleijlevens, Cees A Schumacher, Jan W T Fiolet, Anneke Koeman, Milena Jancev, Markus W Hollmann, Nina C Weber, Ruben Coronel,[...]. Diabetologia 2018
202
33

Efficacy and safety of ivabradine in patients with chronic systolic heart failure and diabetes: an analysis from the SHIFT trial.
Michel Komajda, Luigi Tavazzi, Bernard G Francq, Michael Böhm, Jeffrey S Borer, Ian Ford, Karl Swedberg. Eur J Heart Fail 2015
41
33

Left ventricular systolic and diastolic function, remodelling, and clinical outcomes among patients with diabetes following myocardial infarction and the influence of direct renin inhibition with aliskiren.
Amil M Shah, Sung Hee Shin, Madoka Takeuchi, Hicham Skali, Akshay S Desai, Lars Køber, Aldo P Maggioni, Jean L Rouleau, Roxzana Y Kelly, Allen Hester,[...]. Eur J Heart Fail 2012
35
33

Improved clinical outcomes associated with metformin in patients with diabetes and heart failure.
Dean T Eurich, Sumit R Majumdar, Finlay A McAlister, Ross T Tsuyuki, Jeffrey A Johnson. Diabetes Care 2005
274
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.